Watching the Future
Sitting Down With… Peter Marks
Director of the Center for Biologics Evaluation and Research (CBER) at the FDA, USA
Quotient Sciences CEO talks acquisitions, efficiency and finding cures fast
Mark Egerton, Chief Executive Officer, Quotient Sciences, spoke to Lu Rahman about the company’s acquisition of Arcinova and what it means for the drug discovery sector.